par Pistilli, Barbara;Bellettini, Giulia;Giovannetti, Elisa;Codacci-Pisanelli, Giovanni;Abdel Azim, Hatem Hamdy ;Benedetti, Giovanni;Sarno, Maria Anna;Peccatori, Fedro Alessandro
Référence Cancer treatment reviews, 39, 3, page (207-211)
Publication Publié, 2013-05
Référence Cancer treatment reviews, 39, 3, page (207-211)
Publication Publié, 2013-05
Article révisé par les pairs
Résumé : | An increasing number of women are diagnosed with cancer during pregnancy and lactation. Women are usually advised to interrupt breastfeeding during systemic anticancer treatment for fear of serious adverse effects to the nursed infant. However, the issue is poorly addressed in the literature and very few studies have evaluated the safety of breastfeeding during or after cytotoxic drugs or target agents administration. In this review we will analyze the available evidence that addresses the issue of anticancer drugs, targeted agents, antiemetics and growth-factors excretion in human milk. This could serve as a unique resource that may aid physicians in the management of breastfeeding cancer patients interested in maintaining lactation during treatment. |